There are currently 188 clinical trials in Tulsa, Oklahoma looking for participants to engage in research studies. Trials are conducted at various facilities, including Oklahoma Cancer Specialists and Research Institute-Tulsa, Natalie Warren Bryant Cancer Center at St. Francis Hospital, GSK Investigational Site and Natalie Warren Bryant Cancer Center at Saint Francis. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
NCT05797831
Recruiting
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have achieved complete response or partial response on chemotherapy. The study will be conducted in 2 parts. Part 1 will evaluate safety and efficacy of two different doses of navtemadlin alongside an observational control arm to determine the Phase 3 navtemadlin dose. Part 2 will evaluate the efficacy and safety of navtemadlin Phase 3 dose compared to placebo.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
04/30/2024
Locations: Oklahoma Cancer Specialists and Research Institute, Tulsa, Oklahoma
Conditions: Endometrial Cancer
Register for Updates
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
NCT01656603
Recruiting
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.
Gender:
ALL
Ages:
All
Trial Updated:
04/17/2024
Locations: Southwestern Regional Medical Center, Tulsa, Oklahoma
Conditions: Infusion Reactions
Register for Updates
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
NCT05208671
Recruiting
The NOURISH-OK Study will identify how food insecurity contributes to insulin resistance, an important surrogate marker of many co-morbidities in HIV disease, using an integrated framework to identify key leverage points for insulin resistance. Drawing from these pathways, this study will adapt and evaluate a community-driven, science-informed "food as medicine" intervention designed to lower insulin resistance through healthy food access, food utilization skills, and other self-care behaviors.... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/01/2024
Locations: OU Integrative Immunology Center, Tulsa, Oklahoma
Conditions: HIV, Insulin Resistance, Food Insecurity
Register for Updates
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
NCT04849728
Recruiting
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/24/2024
Locations: Options Health Research, Tulsa, Oklahoma
Conditions: NASH - Nonalcoholic Steatohepatitis
Register for Updates
Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)
NCT02246270
Recruiting
Urinary Tract Infections (UTIs) are the second most common infection in the body. UTIs account for five percent of all visits to primary care physicians. Many women who have had a UTI will develop recurring urinary tract infections. Recent studies suggest that some women who suffer from recurrent UTIs have urinary tracts that allow bacteria to adhere to it more readily than others. Women who suffered from bladder inflammation and recurrent UTIs were noted to have reduced UTIs and bladder inflamm... Read More
Gender:
FEMALE
Ages:
Between 18 years and 85 years
Trial Updated:
12/12/2023
Locations: University of Oklahoma-Tulsa OB/GYN Dept and OU-Physicians, Tulsa, Oklahoma
Conditions: Recurrent Urinary Tract Infections
Register for Updates
Cognitive-Behavioral Therapy for Children With Nightmares
NCT06033781
Recruiting
The goal of this clinical trial is to assess the efficacy of CBT-NC intervention to determine its impact on mental health and suicidality in children ages 6-17. The main aims are: Aim 1: Examine CBT-NC efficacy for improving nightmare distress and frequency in youth with chronic nightmares by comparing the treatment and waitlist group. Aim 2: Examine whether improvements in nightmares relate to fewer mental health problems for youth by determining by comparing the treatment and waitlist group.
Gender:
ALL
Ages:
Between 6 years and 17 years
Trial Updated:
11/15/2023
Locations: University of Tulsa, Tulsa, Oklahoma +1 locations
Conditions: Nightmare, Suicidal Ideation, Children, Only
Register for Updates
Floatation-REST in Methamphetamine Use Disorder: A Pilot Study
NCT05799209
Recruiting
This early-stage trial aims to examine the feasibility, tolerability, and safety of Floatation-REST (Reduced Environmental Stimulation Therapy) or an active comparison condition in 50 individuals receiving treatment for Amphetamine-Type Substance Use Disorder.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
10/04/2023
Locations: Laureate Institute for Brain Research, Tulsa, Oklahoma
Conditions: Amphetamine-Type Substance Use Disorder
Register for Updates
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
NCT05177107
Recruiting
This is a phase IIa randomized trial designed to evaluate bacteriophage therapy in patients with diabetic foot osteomyelitis.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
09/05/2023
Locations: Nextstage Tulsa, Tulsa, Oklahoma
Conditions: Osteomyelitis, Diabetic Foot Osteomyelitis
Register for Updates